BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10149424)

  • 1. Simultaneous measurement of VMA and HVA in 24-hour urine samples.
    Harr R
    Clin Lab Sci; 1991; 4(4):237-41. PubMed ID: 10149424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K; Dugaw K; Benjamin D; Jack RM
    Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
    Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
    J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
    Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
    Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
    Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine using gas chromatography-mass spectrometry (GC/MS).
    Allenbrand R; Garg U
    Methods Mol Biol; 2010; 603():261-9. PubMed ID: 20077077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
    Tang QM; Xu XR; Shi YQ; Jin BX
    Biomed Chromatogr; 1986 Feb; 1(1):7-11. PubMed ID: 3506818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma screening: labeling of HVA and VMA for stable isotope dilution gas chromatography-mass spectrometry.
    Gleispach H; Huber E; Fauler G; Kerbl R; Urban C; Leis HJ
    Nutrition; 1995; 11(5 Suppl):604-6. PubMed ID: 8748233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M; Ramnaraine ML; Woods WG; Krivit W
    Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous analysis of neuroendocrine tumor markers by HPLC-electrochemical detection.
    Manickum T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4140-6. PubMed ID: 19926540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC-ED determination of catecholamines and their metabolites in urine.
    Brandsteterová E; Kubalec P; Skacáni I; Balazovjech I
    Neoplasma; 1994; 41(4):205-11. PubMed ID: 7935993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorometric high performance liquid chromatographic assay for vanillylmandelic acid (VMA) developed from a commercial kit method.
    Huth JA; Bottjen PL; Ludvigsen CW
    Clin Biochem; 1986 Aug; 19(4):221-4. PubMed ID: 3757200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial measurement of urinary VMA and HVA levels from one infant: a study for neuroblastoma mass screening.
    Sawada T; Numata K; Hirata S
    J Pediatr Surg; 1992 Apr; 27(4):452-5. PubMed ID: 1522454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of urinary vanilmandelic acid and homovanillic acid by high-performance liquid chromatography with electrochemical detection following extraction by ion-exchange and ion-moderated partition.
    Binder SR; Sivorinovsky G
    J Chromatogr; 1984 Dec; 336(1):173-88. PubMed ID: 6526918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct concurrent measurement of urinary vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid by HPLC. Three methodologies compared.
    van Haard PM; Wielders JP; Wikkerink JB
    Biomed Chromatogr; 1987; 2(5):209-15. PubMed ID: 2466505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
    Sato Y; Hanai J; Takasugi N; Takeda T
    Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
    Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
    J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.